3D Bioprinting in Reduced Gravity for Tissue Maturation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current bioprinting technologies face challenges in maintaining tissue shape and structure due to gravitational forces, leading to deformation and structural failure, especially when using low-viscosity bioinks, which are necessary for printing complex geometries and promoting cell interaction in reduced gravity environments.

Innovation Solution

A biomanufacturing system and method optimized for reduced gravity environments, utilizing a 3D bioprinter and cell culturing bioreactor that employs low-viscosity bioinks (1-10,000,000 centipoise) to print tissues without external support structures, allowing for faster printing, improved cell motility, and enhanced tissue maturation, while maintaining complex geometries and enclosed voids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If low-viscosity bioinks are used to print complex geometries and promote cell interaction, then cell motility and tissue maturation are improved, but tissue shape and structure deform under gravitational forces

Engineering Contradiction:
Improvecell motilityVSAvoidtissue shape
Core Design Contradiction:
Ease of operationVSShape

Solution Approach 1:

The patent applies the anti-weight principle by operating the bioprinting system in a reduced gravity environment (microgravity or partial gravity), which counteracts the gravitational forces that cause tissue deformation. This allows low-viscosity bioinks to be used without the detrimental effects of gravity-induced deformation, enabling both improved cell motility and maintenance of tissue shape simultaneously.

Inventive Principle:
Principle #8Anti-weight (Counterweight)

2Stability of the object's composition

If external support structures are used to maintain tissue shape, then structural stability is improved, but printing speed decreases and support structures may remain inside tissue

Engineering Contradiction:
Improvestructural stabilityVSAvoidprinting speed
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

By operating in a reduced gravity environment, the patent eliminates the need for external support structures that would be required in terrestrial gravity to prevent deformation. The absence of strong gravitational forces allows tissues to maintain their shape inherently, enabling faster printing without compromising structural stability, and avoiding the risk of support structures remaining embedded in the tissue.

Inventive Principle:
Principle #8Anti-weight (Counterweight)

3Shape

If high-viscosity bioinks are used to maintain tissue structure in gravity, then shape stability is improved, but cell interaction and complex geometry printing are limited

Engineering Contradiction:
Improveshape stabilityVSAvoidcomplex geometry capability
Core Design Contradiction:
ShapeVSAdaptability or versatility

Solution Approach 1:

The reduced gravity environment counteracts the gravitational forces that would cause deformation of low-viscosity bioinks, allowing the use of these materials to print complex geometries and enclose voids. This enables both shape stability and complex geometry capability to be achieved simultaneously, as the bioinks maintain their printed structures without requiring high viscosity for gravitational support.

Inventive Principle:
Principle #8Anti-weight (Counterweight)

Data Source

PatentUS11795422B2Biomanufacturing system, method, and 3D bioprinting hardware in a reduced gravity environment
Publication Date: 2023.10.24 REDWIRE SPACE TECH INC
  • US11795422B2 patent drawing
  • US11795422B2 patent drawing
  • US11795422B2 patent drawing

AI summary

A method, apparatus, and system are provided for the printing and maturation of living tissue in an Earth-referenced reduced gravity environment such as that found on a spacecraft or on other celestial bodies. The printing may be three-dimensional structures. The printed structures may be manufactured from low viscosity biomaterials.